Topic

Prolastin-C (alpha1-proteinase inhibitor)

A collection of 37 issues

Getting Prolastin-C Covered by Blue Cross Blue Shield of Michigan: PA Requirements, Appeals, and State Protections (2024-2025)

Answer Box: How to Get Prolastin-C Covered by BCBS Michigan Blue Cross Blue Shield of Michigan requires prior authorization for Prolastin-C (alpha1-proteinase inhibitor) for commercial members, with specific criteria including confirmed alpha-1 antitrypsin deficiency, nonsmoker status, and symptomatic emphysema. Medicare Plus Blue and BCN Advantage members don't need
6 min read

Getting Prolastin-C Covered by Blue Cross Blue Shield in Virginia: Complete Guide to Prior Authorization, Appeals, and State External Review

Answer Box: Prolastin-C Coverage with Blue Cross Blue Shield in Virginia Blue Cross Blue Shield Virginia requires prior authorization for Prolastin-C (alpha1-proteinase inhibitor) for alpha-1 antitrypsin deficiency. Coverage requires documented severe AATD (like Pi*ZZ genotype), clinical evidence of emphysema, and lung function tests showing moderate impairment (typically FEV1 35-60%
5 min read

How to Get Prolastin-C Covered by UnitedHealthcare in Ohio: Appeals Guide with Forms and Timelines

Answer Box: Getting Prolastin-C Covered by UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization for Prolastin-C (alpha1-proteinase inhibitor), with approvals typically requiring severe AAT deficiency genotype (Pi*ZZ), documented emphysema, and specific lung function criteria. If denied, you have 21 calendar days to appeal through the UnitedHealthcare Provider Portal, followed by
7 min read